Michel van Agthoven
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies 11
- Hematology top 10%
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 15
- Oncology top 10%
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 8
-
- Health Systems, Economic Evaluations, Quality of Life 15
-
- Attention Deficit Hyperactivity Disorder 9
-
- Acute Lymphoblastic Leukemia research 7
-
- Lung Cancer Diagnosis and Treatment 4
-
- Hepatitis C virus research 4
- Co-authors
- Carin A. Uyl‐de GrootC. René LeemansPieter SonneveldBronno van der HoltJan B. OostenbrinkMarc KoopmanschapFrans RuttenPeter C. Levendag
- Partner nations
- NetherlandsUnited StatesBelgium
In The Last Decade
Michel van Agthoven
55 papers receiving 966 citations
Peers
Comparison fields: 5 of 93
- Otorhinolaryngology 250
- Hematology 148
- Pathology and Forensic Medicine 179
- Oncology 265
- Genetics 92
Countries citing papers authored by Michel van Agthoven
This map shows the geographic impact of Michel van Agthoven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel van Agthoven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel van Agthoven more than expected).
Fields of papers citing papers by Michel van Agthoven
This network shows the impact of papers produced by Michel van Agthoven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel van Agthoven. The network helps show where Michel van Agthoven may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michel van Agthoven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 5 | |
| 4 | 2017 | 2 | |
| 5 | 2015 | 14 | |
| 6 | 2015 | 3 | |
| 7 | 2015 | 10 | |
| 8 | 2014 | 1 | |
| 9 | 2014 | 2 | |
| 10 | 2014 | 11 | |
| 11 | 2012 | 1 | |
| 12 | 2008 | 21 | |
| 13 | 2007 | 35 | |
| 14 | 2006 | 79 | |
| 15 | Economic evaluation of prophylactic granulocyte colony stimulating factor during chemotherapy in elderly patients with aggressive non-Hodgkin's lymphoma. | 2004 | 23 |
| 16 | 2004 | 15 | |
| 17 | 2002 | 47 | |
| 18 | 2002 | 9 | |
| 19 | 2001 | 47 | |
| 20 | 2001 | 29 |
About Michel van Agthoven
Michel van Agthoven is a scholar working on Otorhinolaryngology, Pathology and Forensic Medicine and Genetics, having authored 59 papers that have together received 1.0k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (15 papers), Lymphoma Diagnosis and Treatment (15 papers), Head and Neck Cancer Studies (11 papers), Attention Deficit Hyperactivity Disorder (9 papers), Chronic Lymphocytic Leukemia Research (8 papers), Acute Lymphoblastic Leukemia research (7 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Hepatitis C virus research (4 papers). The work is most often cited by research in Otorhinolaryngology (250 citations), Hematology (148 citations) and Pathology and Forensic Medicine (179 citations). Michel van Agthoven has collaborated with scholars based in Netherlands, United States and Belgium. Frequent co-authors include Carin A. Uyl‐de Groot, C. René Leemans, Pieter Sonneveld, Bronno van der Holt, Jan B. Oostenbrink, Marc Koopmanschap, Frans Rutten, Peter C. Levendag, LF Verdonck and Johannes A. Langendijk. Their work appears in journals such as Journal of Clinical Oncology, Blood and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.